These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37186609)

  • 1. Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis.
    Akalu TY; Clements ACA; Baraki AG; Alene KA
    PLoS One; 2023; 18(5):e0285404. PubMed ID: 37186609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of long-term physical sequelae among patients treated with multi-drug and extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Akalu TY; Clements ACA; Wolde HF; Alene KA
    EClinicalMedicine; 2023 Mar; 57():101900. PubMed ID: 36942158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of drug-resistant tuberculosis among contacts of index cases: a protocol for a systematic review.
    Akalu TY; Clements ACA; Gebreyohannes EA; Wolde HF; Shiferaw FW; Alene KA
    BMJ Open; 2024 Jan; 14(1):e074364. PubMed ID: 38195168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis.
    Alene KA; Clements ACA; McBryde ES; Jaramillo E; Lonnroth K; Shaweno D; Viney K
    BMJ Open; 2018 Feb; 8(2):e019593. PubMed ID: 29440162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis.
    Akalu TY; Clements ACA; Wolde HF; Alene KA
    Sci Rep; 2023 Dec; 13(1):22361. PubMed ID: 38102144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis.
    Alemu A; Bitew ZW; Diriba G; Gashu E; Seid G; Eshetu K; Kebede A; Gumi B
    BMJ Open; 2023 Apr; 13(4):e070143. PubMed ID: 37019479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
    Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
    Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant surgical resection for multidrug-resistant tuberculosis: A review].
    Mordant P; Henry B; Morel S; Robert J; Veziris N; Le Dû D; Frechet-Jachym M; Similowski T; Caumes É; Riquet M; Le Pimpec-Barthes F
    Rev Mal Respir; 2014 Jun; 31(6):511-24. PubMed ID: 25012037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis.
    Sultana ZZ; Hoque FU; Beyene J; Akhlak-Ul-Islam M; Khan MHR; Ahmed S; Hawlader DH; Hossain A
    BMC Infect Dis; 2021 Jan; 21(1):51. PubMed ID: 33430786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan.
    Makhmudova M; Maxsumova Z; Rajabzoda A; Makhmadov A; van den Hof S; Mirtskhulava V
    Int J Tuberc Lung Dis; 2019 Mar; 23(3):331-336. PubMed ID: 30871664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory-Based Surveillance of Extensively Drug-Resistant Tuberculosis in Eastern China.
    Huang Y; Wu Q; Xu S; Zhong J; Chen S; Xu J; Zhu L; He H; Wang X
    Microb Drug Resist; 2017 Mar; 23(2):236-240. PubMed ID: 27754791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-extensively drug-resistant and extensively drug-resistant tuberculosis in Latin America and the Caribbean: A systematic review and meta-analysis.
    Alarcon-Braga EA; Salazar-Valdivia FE; Estrada-Grossmann JM; Mendez-Guerra C; Pacheco-Barrios N; Al-Kassab-Córdova A
    Am J Infect Control; 2024 Mar; 52(3):349-357. PubMed ID: 38061402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional study about knowledge and attitudes toward multidrug-resistant and extensively drug-resistant tuberculosis in a high-burden drug-resistant country.
    Javed H; Tahir Z; Hashmi HJ; Jamil N
    Int J Mycobacteriol; 2016 Jun; 5(2):128-34. PubMed ID: 27242222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of potentially infectious tuberculosis and multidrug-resistant tuberculosis (MDR-TB) among hospital inpatients in KwaZulu Natal, South Africa indicate risk of nosocomial transmission.
    Bantubani N; Kabera G; Connolly C; Rustomjee R; Reddy T; Cohen T; Pym AS
    PLoS One; 2014; 9(3):e90868. PubMed ID: 24625669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.